Neurotrophic factor therapy for Parkinson's disease: past, present and future
Aideen M.Sullivan
Gerard W.O'Keeffe
摘要：One of the greatest unmet needs in the treatment of Parkinson's disease (PD) is a disease-modifying therapy,which can halt the ongoing degeneration of dopaminergic neurons that is characteristic of this disorder.Current therapies focus on managing symptoms,rather than on addressing their cause.Promising candidates for disease-modifying therapies are the dopaminergic neurotrophic factors (NTFs).NTFs are secreted proteins which play critical roles in the developing nervous system,directing and supporting the specification,maturation and survival of specific neuronal populations.Several dopaminergic NTFs have shown great potential in animal models of PD,conferring protective and regenerative effects on the nigrostriatal dopaminergic neurons which undergo progressive degeneration in this disease (for reviews see Sullivan and Toulouse,2011;Hegarty et al.,2014a).
机标关键词：dopaminergic neuronsneurotrophic factorssecreted proteinsnervous systemanimal models
论文发表日期：2016-01-01
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：3( 205-207 )
英文信息